Lipohypertrophy
13
1
2
7
Key Insights
Highlights
Success Rate
70% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 74/100
23.1%
3 terminated out of 13 trials
70.0%
-16.5% vs benchmark
0%
0 trials in Phase 3/4
43%
3 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (13)
Effects of Semaglutide in HIV-Associated Lipohypertrophy
Glucose Variability in Subclinical Hypertrophy
Innovative Insulin Injection Sites Map to Minimize Lipohypertrophy Risk
The Use of Ultrasound Detection of Lipohypertrophy to Improve Glycemic Control
Evaluation of Raltegravir Plus Maraviroc Therapy in Controlled HIV Patients Presenting With Lipohypertrophy
De-tensioning Patch, in Subjects With Type 1 Diabetes and Lipohypertrophy
Ultrasound Detection and Characterization of Subclinical Hypertrophy in Diabetes
Dynamics of Insulin Absorption in Subclinical Lipohypertrophy Using the Euglycemic Clamp Technique
The Role of Proper Insulin Injection Technique in the Treatment of Diabetes Mellitus
The Visceral Adiposity Measurement and Observation Study
Impact of Two Medtronic Infusion Sets on Lipohypertrophy in Type 1 Diabetes (T1DM) Patients Thought to Have LH
Lipohypertrophy Monitoring Study
Ultrasound Classification and Grading of Lipohypertrophy and Its Impact on Glucose Variability in Type 1 Diabetes